Acute Effects of Typical and Atypical Antipsychotic Drugs on the Release of Dopamine from Prefrontal Cortex, Nucleus Accumbens, and Striatum of the Rat: An In Vivo Microdialysis Study

Journal of Neurochemistry

Volumn 54, Issue 5, 1990, Pages 1755-1760

  Moghaddam, Bita ^a   Bunney, Benjamin S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Clozapine; Dopamine; Haloperidol; Microdialysis; Nucleus accumbens; Prefrontal cortex; Striatum; Sulpiride

Indexed keywords

CLOZAPINE; HALOPERIDOL; SULPIRIDE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN PERFUSION; CORPUS STRIATUM; DIALYSIS; DOPAMINE RELEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT;

ANIMAL; ANTIPSYCHOTIC AGENTS; CLOZAPINE; CORPUS STRIATUM; DIALYSIS; DOPAMINE; FRONTAL LOBE; HALOPERIDOL; MALE; NUCLEUS ACCUMBENS; RATS; RATS, INBRED STRAINS; SEPTAL NUCLEI; SULPIRIDE; SUPPORT, U.S. GOV'T, P.H.S.;

ANIMALIA;

EID: 0025239750     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.1990.tb01230.x     Document Type: Article

References (62)

1. Dopaminergic turnover in the corpus striatum and the limbic system after treatment with APD and antiacetylcholinergic drugs
2. Effects of clozapine on the turnover of dopamine in the corpus striatum and in the limbic system
3. Antipsychotic drug action in schizophrenic patients: effect of cortical dopamine metabolism after long‐term treatment
4. Pathophysiologic basis of tardive dyskinesia
5. Mesocortical dopamine neurons: lack of autoreceptors modulating dopamine synthesis
6. Unique response to antipsychotic drugs is due to absence of terminal autoreceptors in mesocortical dopamine neurons
7. Differential effect of APD drugs on dopamine turnover in the extrapyramidal and limbic system
8. Histochemical confirmation for dopaminergic innervation of the rat cerebral cortex after destruction of the noradrenergic ascending pathway
9. The effect of antipsychotic drugs on the firing of dopaminergic neurons: a reappraisal
10. The precise localization of nigral afferents in the rat as determined by the retrograde tracing technique
11. Acute and chronic haloperidol treatment: comparison of effects on nigral dopaminergic cell activity
12. Electrophysiological identification and pharmacological characterization of dopamine sensitive neurons in the rat prefrontal cortex
13. Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity
14. Mechanism of action of APD drugs
15. Effect of chlorpromazine and haloperidol on formation of 3‐methoxytyramine and normetanephrine in mouse brain
16. Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons
17. Evidence for the absence of impulse regulating somatodendritic and synthesis‐modulating nerve terminal autoreceptors on subpopulations of mesocortical dopamine neurons
18. Rapid sampling and determination of extracellular dopamine in vivo
19. Clozapine efficacy in schizophrenic nonresponders
20. Evidence for the existence of monoamine‐containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons
21. Clozapine, a novel major tranquilizer
22. Footshock and conditioned stress increase DOPAC in the ventral tegmental area but not substantia nigra
23. The origin and distribution of dopamine‐containing afferents to the rat frontal cortex
24. Evidence for dopamine autoreceptors in mesocortical neurons
25. Clozapine–a serotonin antagonist
26. Regulation of dopamine synthesis in the medial prefrontal cortex is mediated by release modulating autoreceptors: studies in vivo
27. Effects of neuroleptics on the nigroneostriatal and mesocortical dopaminergic systems
28. Self inhibition of dopaminergic neurons
29. Dopamine nerve terminals in the rat limbic cortex: aspects of the dopamine hypothesis of schizophrenia
30. Dopamine release in nucleus accumbens and striatum by clozapine: simultaneous monitoring by in vivo electrochemistry
31. Dopamine release and metabolism in awake rats after systemic neuroleptics as studied by trans‐striatal dialysis
32. Anatomy of the dopaminergic neuron systems in the rat brain
33. Antipsychotic drug actions: a clue to the neuropathology of schizophrenia
34. Comparative effects of clozapine and alpha‐adrenoreceptor blocking drugs on regional noradrenaline metabolism in rat brain
35. Application of high performance liquid chromatography with electrochemical detection to neurochemical analysis: measurement of catecholamines, serotonin, and metabolites in rat brain
36. Ionic composition of microdialysis perfusing solution alters the basal release and pharmacological responsiveness of striatal dopamine
37. Differential effect of cocaine on extracellular dopamine levels in the rat medial prefrontal cortex and nucleus accumbens: a comparison with amphetamine
38. Differences in dopamine release and metabolism in rat striatal subregions following acute clozapine using in vivo microdialysis
39. cis‐Flupentixol antagonism of the rat prefrontal cortex neuronal response to apomorphine and ventral tegmental area input
40. Biochemical correlate of the electrophysiological activity of dopaminergic neurons: reflections on two decades of collaboration with electrophysiologists
41. Differential regional development of tolerance to increase in dopamine turnover upon repeated neuroleptic administration
42. Acute and subacute effects of neuroleptics on dopamine synthesis and release in the rat striatum
43. Dopamine receptor in brain and periphery
44. Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons
45. In vivo voltammetric measurement of extracellular DOPAC levels in the anteromedial prefrontal cortex of the rat
46. Pharmacological characterization of receptor mediating electrophysiological responses to dopamine in the rat medial prefrontal cortex: a microiontophoretic study
47. Drugs, neurotransmitters, and schizophrenia
48. Extrapyramidal syndromes and other neurological side effects of psychotropic drugs
49. In vivo effect of endogenous neurotransmitters in cat limbic regions: effect of chlorpromazine and electrical stimulation
50. Actions of dopamine antagonists on stimulated striatal and limbic dopamine release: an in vivo voltammetric study
51. An anatomy of schizophrenia
52. Dopaminergic terminals in the rat cortex
53. Selective activation of mesocortical DA system by stress
54. Effects of stimulation of the frontal cortex on identified output VMT cells in the rat
55. Variation in the ability of neuroleptics to block the inhibitory influence of dopaminergic neurons on the activity of cells in the rat medial prefrontal cortex
56. Measurement of neurotransmitter release by intracranial dialysis
57. Dopaminergic neurons in the rat ventral tegmental area. II. Evidence for auto regulation
58. Differential effect of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons
59. Dopamine neurons projecting to the medial prefrontal cortex possess release‐modulating autoreceptors
60. Effect of neuroleptics drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis
61. In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine‐releasing drugs; implications for the origin of extracellular DOPAC